Abbott Laboratories (ABT)
113.65
+0.17
(+0.15%)
USD |
NYSE |
Mar 28, 16:00
113.41
-0.24
(-0.21%)
After-Hours: 18:45
Abbott Laboratories Cash from Operations (TTM): 7.261B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 7.261B |
September 30, 2023 | 6.549B |
June 30, 2023 | 7.452B |
March 31, 2023 | 8.659B |
December 31, 2022 | 9.581B |
September 30, 2022 | 10.32B |
June 30, 2022 | 10.24B |
March 31, 2022 | 9.961B |
December 31, 2021 | 10.53B |
September 30, 2021 | 11.26B |
June 30, 2021 | 10.63B |
March 31, 2021 | 9.823B |
December 31, 2020 | 7.901B |
September 30, 2020 | 6.519B |
June 30, 2020 | 6.401B |
March 31, 2020 | 6.139B |
December 31, 2019 | 6.136B |
September 30, 2019 | 5.485B |
June 30, 2019 | 5.72B |
March 31, 2019 | 5.904B |
December 31, 2018 | 6.30B |
September 30, 2018 | 6.175B |
June 30, 2018 | 5.997B |
March 31, 2018 | 6.104B |
December 31, 2017 | 5.57B |
Date | Value |
---|---|
September 30, 2017 | 5.10B |
June 30, 2017 | 4.312B |
March 31, 2017 | 3.87B |
December 31, 2016 | 3.203B |
September 30, 2016 | 2.861B |
June 30, 2016 | 2.839B |
March 31, 2016 | 2.871B |
December 31, 2015 | 2.966B |
September 30, 2015 | 3.376B |
June 30, 2015 | 3.382B |
March 31, 2015 | 3.341B |
December 31, 2014 | 3.675B |
September 30, 2014 | 4.062B |
June 30, 2014 | 3.383B |
March 31, 2014 | 3.20B |
December 31, 2013 | 3.324B |
September 30, 2013 | 3.202B |
June 30, 2013 | 6.199B |
March 31, 2013 | 7.549B |
December 31, 2012 | 9.314B |
September 30, 2012 | 9.213B |
June 30, 2012 | 8.747B |
March 31, 2012 | 9.184B |
December 31, 2011 | 8.97B |
September 30, 2011 | 9.885B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
5.485B
Minimum
Sep 2019
11.26B
Maximum
Sep 2021
8.124B
Average
7.676B
Median
Cash from Operations (TTM) Benchmarks
Boston Scientific Corp | 2.503B |
Haemonetics Corp | 197.28M |
Insulet Corp | 145.70M |
Stryker Corp | 3.711B |
Tandem Diabetes Care Inc | -31.81M |